Insider holders · CIK 0001637715
OnKure Therapeutics, Inc. · OKUR
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Jason A. LeveroneChief Financial Officer | 18,500 | — | 18,500 | Sep 23, 2026 · 4:52 pm EDT | Form 4 |
| Nicholas A SaccomanoPresident and CEO | 11,160 | — | 11,160 | Sep 23, 2026 · 4:54 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.